Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement

Journal of Nutrition

Volumn 129, Issue 5, 1999, Pages 919-922

  Bailey, Lynn B ^a   Gregory III, Jesse F ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cancer; Folate; Homocysteine; MTHFR polymorphism; Neural tube defects; Vascular disease

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; CANCER RISK; CARDIOVASCULAR RISK; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENETIC POLYMORPHISM; NEURAL TUBE DEFECT; REVIEW; RISK FACTOR; VITAMIN INTAKE; VITAMIN METABOLISM;

EID: 0032906750     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/129.5.919     Document Type: Review

References (41)

1. Abbate, R., Sardi, I., Pepe, G., Marcucci, R., Brunelli, T., Prisco, D., Fatini, C., Capanni, M., Simonetti, I. & Gensini, G. F. (1998) The high prevalence of thermolabite 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb. Haemost. 79: 727-730.
2. Austin, H., Hooper, W. C., Dilley, A., Drews, C., Renshaw, M., Ellingsen, D. & Evatt, B. (1997) The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans. Thromb. Res. 86: 409-415.
3. Bagley, P. J. & Selhub, J. (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of non-methylated tetrahydrofolate in red blood cells. Proc. Natl. Acad. Sci. U.S.A. 95: 13217-13220.
4. Bailey, L. B. & Gregory, J. F. (1999) Folate metabolism and requirements. J. Nutr. 129: 779-782.
5. Blount, B. C., Mack, M. M., Wehr, C. M., MacGregor, J. T., Hiatt, R. A., Wang, G., Wickramasinghe, S. N., Everson, R. B. & Ames, B. N. (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. U.S.A. 94: 3290-3295.
6. Brattstrom, L., Wilchen, D.E.I, Ohrvik, J. & Brudin, L. (1998) Common methylenetetrahydrofotate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease - the result of a meta-analysis. Circulation 98: 2520-2526.
7. Chen, J., Giovannucci, E., Hankinson, S. E., Ma, J., Willett, W. C., Spiegelman, D., Kelsey, K. T. & Hunter, D. J. (1998) A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19: 2129-2132.
8. Chen, J., Giovannucci, E. L. & Hunter, D. J. (1999) MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J. Nutr. 129: 560S-564S.
9. Chen, J., Giovannucci, E., Kelsey, K., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Speigelman, D., Willett, W. C. & Hunter D. J. (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56: 4862-4864.
10. Chen, L. H., Liu, M.-L., Hwang, H.-Y., Korenberg, J. & Shane, B. (1997) Human methionine synthase. cDNA cloning, gene localization, and expression. J. Biol. Chem. 272: 3628-3634.
11. Daly, L. E., Kirke, P. N., Molloy, A. M., Weir, D. G. & Scott, J. M. (1995) Folate levels and neural tube defects: implications for prevention. J. Am. Med. Assoc. 272: 1698-1702.
12. Franco, R. F., Araujo, A. G., Guerreiro, J. F., Elion, J. & Zago, M. A. (1998) Analysis of the 677C → T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb. Haemost.79: 119-121.
13. Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G.J.H, den Heijer, M., Kluijtmans, L.A.J, van den Heuvel, L. P. & Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahyrofolate reductase. Nat. Genet. 10: 111-113.
14. Gudnason, V., Stansbie, D., Scott, J., Browron, A., Nicaud, V. & Humphries, S. (1998) C677T (thermolabile alanina/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis 136: 347-354.
15. Jacques, P. F., Bostom, A. G., Williams, R. R., Ellison, R. C., Eckfeldt, J. H., Rosenberg, I. H., Selhub, J. & Rosen, R. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93: 7-9.
16. Kang, S. S. & Wong, P. W. (1996) Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 119: 135-138.
17. Loehrer, F.M.T, Angst, C. P., Haefeli, W. E., Jordan, P. P., Ritz, R. & Fowler, B. (1996) Low whole-blood S-adenosylmethionine and correlation between 5-methyltrahydrofolate and homocysteine in coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16: 727-733.
18. Ma, J., Stampfer, M. J., Giovannucci, E., Artigas, C., Hunter, D. J., Fuchs, C., Willett, W. C., Selhub, J., Hennekens, C. H. & Rozen, R. (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57: 1098-1102.
19. Malinow, M. R., Nieto, F. J., Kruger, W. D., Duell, P. B., Hess, D. L., Gluckman, R. A., Block, P. C., Holzgang, C. R., Anderson, P. H., Seltzer, D., Upson, B. & Lin, Q. R. (1997) The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler. Thromb. Vasc. Biol. 17: 1157-1162.
20. Matthews, R. G., Sheppard, C. & Goulding, C. (1998) Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur. J. Pediatr. 157 (suppl. 2): S54-S59.
21. McAndrew, P. E., Brandt, J. T., Pearl, D. K. & Prior, T. W. (1995) The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African Americans. Thromb. Res. 83: 195-198.
22. Molloy, A. M., Daly, S., Mills, J. L., Whitehead, A. S. Ramsbottom, D., Conley, M. R., Weir, D. G. & Scott, J. M. (1997) Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349: 1591-1593.
23. Molloy, A. M., Mills, J. L. Kirke, P. N., Ramsbottom, D., McPartlin, J. M., Burke, H., Conley, M., Whitehead, A. S., Weir, D. G. & Scott, J. M. (1998) Low blood folates in NTD pregnancies are only partly explained by thermolabile methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am. J. Genet. 78: 155-159.
24. Mornet, E., Muller, F., Lenvoise-Furet, A., Delezoide, A.-L., Jean-Yves, C., Simon-Bouy, B. & Serre, J.-L. (1997) Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum. Genet. 100: 512-514.
25. Nelen, W.L.D.M., Blom, H. J., Thomas, C.M.G, Steegers, E.A.P, Boers, G.H.J & Eskes, T.K.A.B. (1998) Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J. Nutr. 128: 1336-1341.
26. Nygård, O., Vollset, S. E., Refsum, H., Stensvold, I., Tverdal, A., Nordrehaug, J. E., Ueland, P. M. & Kvåle, G. (1995) The Hordaland homocysteine study. Total plasma homocysteine and cardiovascular risk profile. J. Am. Med. Assoc. 274: 1526-1533.
27. Ou, C. Y., Stevenson, R. E., Brown, V. K., Schwartz, C. E., Allen, W. P., Khoury, M. J., Rozen, R., Oakley, G. P. & Adams, M. J. (1996) 5,10-Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am. J. Med. Genet. 63: 610-614.
28. Refsum, H., Guttormsen, A. B., Fiskerstrand, T. & Ueland, P. M. (1998) Hyperhomocysteinemia in terms of steady state kinetics. Eur. J. Pediatr. 157 (suppl. 2): S45-S49.
29. Refsum, H. & Ueland, P. M. (1998) Recent data are not in conflict with homocysteine as a cardiovascular risk factor. Curr. Opin. Lipidol. 9: 533-539.
30. Rosenberg, I. H. & Rosenberg, L. E. (1998) The implications of genetic diversity for the nutrient requirements: the case of folate. Nutr. Rev. 56: S47-S53.
31. Scott, J. M., Kirke, P. N. & Weir, D. G. (1995) Folate and neural tube defects. In: Folate in Health and Disease (Bailey L. B., ed.), pp. 329-360, Marcel Dekker, New York, NY.
32. Stampfer, M. J., Malinow, M. R., Willett, W. C., Newcomer, L. M., Upson, B., Ullmann, D., Tishler, P. V. & Hennekens, C. H. (1992) A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J. Am. Med. Assoc. 268: 877-881.
33. Stevenson, R. E., Schwartz, C. E., Du, Y. Z. & Adams, M. J. (1997) Differences in methylenetetrahydrofolate reductase genotype frequencies, between Whites and Blacks. Am. J. Hum. Genet. 60: 229-230.
34. Ulvik, A., Ren, J., Refsum, H. & Ueland, P. M. (1998) Simultaneous determination of methylenetetrahydrofolate reductase C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary etectrophoresis. Clin. Chem. 44: 264-269.
35. van der Put, N. M., Eskes, T. K. & Blom, H. J. (1997a) Is the common 677C → T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Quart. J. Med. 90: 111-115.
36. van der Put, N. M., Gabreels, F., Stevens, E. M., Smeitink, J. A., Trijbels, F. J., Eskes, T. K., van den Heuvel, L. P. & Blom, H. J. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am. J. Hum. Genet. 62: 1044-1051.
37. van der Put, N. M., Steegers-Theunissen, R. P., Frosst, P., Trijbels, F. J., Eskes, T. K., van den Heuvel, L. P., Mariman, E. C., der Heyer, M., Roxen, R. & Blom, H. J. (1995) Mutated methylenehydrofolate reductase as a risk factor for spina bifida. Lancet 346: 1070-1071.
38. van der Put, N. M., van der Molen, E. F., Kluijtmans, L. A., Heil, S. G., Trijbels, J. M., Eskes, T. K., Van Oppenraaij-Emmerzaal, D., Banerjee, R. & Blom, H. J. (1997b) Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Quart. J. Med. 90: 511-517.
39. Verhoef, P., Rimm, E. B., Hunter, D. J., Chen, J., Willett, W. C., Kelsey, K. & Stampfer, M. J. (1997) Methylenetetrahydrofolate reductase polymorphism, diet, and risk of coronary heart disease among men. 16th International Congress of Nutrition, July 27-August 1, Montreal, Canada. Abstract PW3.12.
40. Whitehead, A. S., Gallagher, P., Mills, J. L., Kirke, P. N., Burke, H., Molloy, A. M., Weir, D. G., Shields, D. C. & Scott, J.M.A. (1995) A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q. J. Med. 88: 763-766.
41. Wilcken, D., Wang, X. L., Sim, A. S. & McCredie, M. (1996) Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler. Thromb. Vasc. Biol. 16: 878-882.